PT

Paul Thomas

Director Director DIN 01208952
DIN 01208952 First appointment Sep 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2001
Shareholding value •••• Premium profile

About Paul Thomas

Data last updated:

Paul Thomas was a Director at Sance Laboratories Private Limited (2001–2021) and Director at Sance Parenterals Private Limited (2001–2021). The companies operate in Pharma.

DIN 01208952
Primary Designation Director
Industry Pharma
First Appointment 03 Sep 2001

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sance Laboratories Private Limited U24231KL2001PTC014957
Director20 Sep 20012001₹64.38 Cr (FY 2025)Active
Sance Parenterals Private Limited U24231KL2001PTC014916
Director03 Sep 20012001₹2.1 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sance Laboratories Private Limited
Sance Parenterals Private Limited
Premium access

Shareholding and investment profile for Paul Thomas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paul Thomas

Paul Thomas was first appointed on 03 Sep 2001 as Director at Sance Parenterals Private Limited.

Paul Thomas held 2 earlier board appointments: Sance Laboratories Private Limited (Director, 20 Sep 2001 to 26 Aug 2021); Sance Parenterals Private Limited (Director, 03 Sep 2001 to 26 Aug 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available